Skip to main content
PMC home page
Neurotherapeutics logoLink to Neurotherapeutics
. 2010 Apr;7(2):183–190. doi: 10.1016/j.nurt.2010.03.006

Nitric oxide-related drag targets in headache

Jes Olesen 1,✉
PMCID: PMC5084099  PMID: 20430317

Summary

Nitric oxide (NO) is a very important molecule in the regulation of cerebral and extra cerebral cranial blood flow and arterial diameters. It is also involved in nociceptive processing. Glyceryl trinitrate (GTN), a pro-drug for NO, causes headache in normal volunteers and a so-called delayed headache that fulfils criteria for migraine without aura in migraine sufferers. Blockade of nitric oxide synthases (NOS) by L-nitromonomethylarginine effectively treats attacks of migraine without aura. Similar results have been obtained for chronic the tension-type headache and cluster headache. Inhibition of the breakdown of cyclic guanylate phosphate (cGMP) also provokes migraine in sufferers, indicating that cGMP is the effector of NO-induced migraine. Similar evidence suggests an important role of NO in the tension-type headache and cluster headache. These very strong data from human experimentation make it highly likely that antagonizing NO effects will be effective in the treatment of primary headaches. Nonselective NOS inhibitors are likely to have side effects whereas selective compounds are now in early clinical trials. Antagonizing the rate limiting cofactor tetrahydrobiopterin seems another very likely new treatment. It is more unlikely that antagonism of cGMP or its formation will be feasible, but augmenting its breakdown via phosphodiesterase activation is a possibility, as well as other ways of inhibiting the NO-cGMP pathway.

Key Words: Cerebral circulation, drug development, experimental headache, headache, nitroglycerin, pain

References

  • 1.Olesen J, Thomsen LL, Iversen H. Nitric-oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci. 1994;15:149–153. doi: 10.1016/0165-6147(94)90075-2. [DOI] [PubMed] [Google Scholar]
  • 2.Lassen LH, Ashina M, Christiansen I, Ulrich V, Olesen J. Nitric oxide synthase inhibition in migraine. Lancet. 1997;349:401–402. doi: 10.1016/S0140-6736(97)80021-9. [DOI] [PubMed] [Google Scholar]
  • 3.Marsh N, Marsh A. A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clin Exp Pharmacol Physiol. 2000;27:313–319. doi: 10.1046/j.1440-1681.2000.03240.x. [DOI] [PubMed] [Google Scholar]
  • 4.Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol. 2006;147:S193–S201. doi: 10.1038/sj.bjp.0706458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bredt DS. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res. 1999;31:577–596. doi: 10.1080/10715769900301161. [DOI] [PubMed] [Google Scholar]
  • 6.Edvinsson L, Krause D. Cerebral blood flow and metabolism. Philadelphia: Lippincott: Williams and Wilkins; 2002. [Google Scholar]
  • 7.Messlinger K, Suzuki A, Pawlak M, Zehnter A, Schmidt RF. Involvement of nitric oxide in the modulation of dural arterial blood flow in the rat. Br J Pharmacol. 2000;129:1397–1404. doi: 10.1038/sj.bjp.0703220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Moncada S, Higgs EA. Nitric oxide and the vascular endothelium. Handb Exp Pharmacol 2006;(176 Pt 1):213–254. [DOI] [PubMed]
  • 9.Edvinsson L, Mulder H, Goadsby PJ, Uddman R. Calcitonin generelated peptide and nitric oxide in the trigeminal ganglion: Cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. J Auton Nerv Syst. 1998;70:15–22. doi: 10.1016/S0165-1838(98)00033-2. [DOI] [PubMed] [Google Scholar]
  • 10.Ayajiki K, Fujioka H, Okamura T, Toda N. Relatively selective neuronal nitric oxide synthase inhibition by 7-nitroindazole in monkey isolated cerebral arteries. Eur J Pharmacol. 2001;6:423–423. doi: 10.1016/s0014-2999(01)01068-8. [DOI] [PubMed] [Google Scholar]
  • 11.Toda N. Mediation by nitric-oxide of neurally-induced human cerebral-artery relaxation. Experientia. 1993;49:51–53. doi: 10.1007/BF01928789. [DOI] [PubMed] [Google Scholar]
  • 12.Toda N, Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev. 2003;55:271–324. doi: 10.1124/pr.55.2.3. [DOI] [PubMed] [Google Scholar]
  • 13.Toda N, Ayajiki K, Tanaka T, Okamura T. Preganglionic and postganglionic neurons responsible for cerebral vasodilation mediated by nitric oxide in anesthetized dogs. J Cereb Blood Flow Metab. 2000;20:700–708. doi: 10.1097/00004647-200004000-00007. [DOI] [PubMed] [Google Scholar]
  • 14.Dahl A, Russell D, Nyberg-Hansen R, Rootwelt K. Cluster headache: transcranial Doppler ultrasound and rCBF studies. Cephalalgia. 1990;10:87–94. doi: 10.1046/j.1468-2982.1990.1002087.x. [DOI] [PubMed] [Google Scholar]
  • 15.Lassen LH, Christiansen I, Iversen HK, Jansen-Olesen I, Olesen J. The effect of nitric oxide synthase inhibition on histamine induced headache and arterial dilatation in migraineurs. Cephalalgia. 2003;23:877–886. doi: 10.1046/j.1468-2982.2003.00586.x. [DOI] [PubMed] [Google Scholar]
  • 16.Lassen L, Sperling B, Andersen A, Olesen J. The effect of i.v. L-NG methylarginine hydrochloride (L-NMMA: 546C88) on basal and acetazolamide (Diamox) induced changes of blood velocity in cerebral arteries and regional cerebral blood flow in man. Cephalalgia. 2005;25:344–352. doi: 10.1111/j.1468-2982.2004.00862.x. [DOI] [PubMed] [Google Scholar]
  • 17.Fabricius M, Lauritzen M. Examination of the role of nitric-oxide for the hypercapnic rise of cerebral blood-flow in rats. Am J Physiol. 1994;266:H1457–H1464. doi: 10.1152/ajpheart.1994.266.4.H1457. [DOI] [PubMed] [Google Scholar]
  • 18.Fabricius M, Akgoren N, Lauritzen M. Arginine nitric-oxide pathway and cerebrovascular regulation in cortical spreading depression. Am J Physiol Heart Circ Physiol. 1995;38:H23–H29. doi: 10.1152/ajpheart.1995.269.1.H23. [DOI] [PubMed] [Google Scholar]
  • 19.Berger RJ, Zuccarello M, Keller JT. Nitric-oxide synthase immunoreactivity in the rat dura-mater. Neuroreport. 1994;5:519–521. doi: 10.1097/00001756-199401120-00039. [DOI] [PubMed] [Google Scholar]
  • 20.Nemade RV, Lewis AI, Zuccarello M, Keller JT. Immunohistochemical localization of endothelial nitric-oxide synthase in vessels of the dura-mater of the Sprague-Dawley rat. Neurosci Lett. 1995;197:78–80. doi: 10.1016/0304-3940(95)11887-3. [DOI] [PubMed] [Google Scholar]
  • 21.Gozalov A, Jansen-Olesen I, Klaerke D, Olesen J. Role of BKCa channels in cephalic vasodilation induced by CGRP, NO and transcranial electrical stimulation in the rat. Cephalalgia. 2007;27:1120–1127. doi: 10.1111/j.1468-2982.2007.01409.x. [DOI] [PubMed] [Google Scholar]
  • 22.Johnson KW, Nelson DL, Dieckman DK, et al. Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation. Cephalalgia. 2003;23:117–123. doi: 10.1046/j.1468-2982.2003.00464.x. [DOI] [PubMed] [Google Scholar]
  • 23.Iversen HK. N-Acetylcysteine enhances nitroglycerin-induced headache and cranial arterial responses. Clin Pharmacol Ther. 1992;52:125–133. doi: 10.1038/clpt.1992.121. [DOI] [PubMed] [Google Scholar]
  • 24.De Col R, Koulchitsky SV, Messlinger KB. Nitric oxide synthase inhibition lowers activity of neurons with meningeal input in the rat spinal trigeminal nucleus. Neuroreport. 2003;10:229–232. doi: 10.1097/00001756-200302100-00014. [DOI] [PubMed] [Google Scholar]
  • 25.Hoskin KL, Bulmer DC, Goadsby PJ. Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME. Neurosci Lett. 1999;266:173–176. doi: 10.1016/S0304-3940(99)00281-5. [DOI] [PubMed] [Google Scholar]
  • 26.Lambert GA, Hoskin KL, Zagami AS. Nitrergic and glutamatergic neuronal mechanisms at the trigeminovascular first-order synapse. Neuropharmacology. 2004;47:92–105. doi: 10.1016/j.neuropharm.2004.03.006. [DOI] [PubMed] [Google Scholar]
  • 27.Jones MG, Lever I, Bingham S, Read S, McMahon SB, Parsons A. Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat. Cephalalgia. 2001;21:643–655. doi: 10.1046/j.1468-2982.2001.00213.x. [DOI] [PubMed] [Google Scholar]
  • 28.Koulchitsky S, Fischer MJM, De Col R, Schlechtweg PM, Messlinger K. Biphasic response to nitric oxide of spinal trigeminal neurons with meningeal input in rat-possible implications for the pathophysiology of headaches. J Neurophysiol. 2004;92:1320–1328. doi: 10.1152/jn.01210.2003. [DOI] [PubMed] [Google Scholar]
  • 29.Iversen HK, Nielsen TH, Garre K, Tfelthansen P, Olesen J. Dose-dependent headache response and dilation of limb and extracranial arteries after 3 doses of 5-isosorbide-mononitrate. Eur J Clin Pharmacol. 1992;42:31–35. doi: 10.1007/BF00314916. [DOI] [PubMed] [Google Scholar]
  • 30.Olesen J, Thomsen LL, Lassen LH, Olesen IJ. The nitric-oxide hypothesis of migraine, and other vascular headaches. Cephalalgia. 1995;15:94–100. doi: 10.1046/j.1468-2982.1995.015002094.x. [DOI] [PubMed] [Google Scholar]
  • 31.Sicuteri F, Delbene E, Poggioni M, Bonazzi A. Unmasking latent dysnociception in healthy-subjects. Headache. 1987;27:180–185. doi: 10.1111/j.1526-4610.1987.hed2704180.x. [DOI] [PubMed] [Google Scholar]
  • 32.Iversen HK, Olesen J, Tfelthansen P. Intravenous nitroglycerin as an experimental-model of vascular headache—basic characteristics. Pain. 1989;38:17–24. doi: 10.1016/0304-3959(89)90067-5. [DOI] [PubMed] [Google Scholar]
  • 33.Iversen HK, Nielsen TH, Tfelthansen P, Olesen J. Lack of tolerance of headache and radial artery diameter during a 7 hour intravenous-infusion of nitroglycerin. Eur J Clin Pharmacol. 1993;44:47–50. doi: 10.1007/BF00315279. [DOI] [PubMed] [Google Scholar]
  • 34.Christiansen I, Daugaard D, Thomsen LL, Olesen J. Glyceryl trinitrate induced headache in migraineurs: relation to attack frequency. Eur J Neurol. 2000;7:405–411. doi: 10.1046/j.1468-1331.2000.00094.x. [DOI] [PubMed] [Google Scholar]
  • 35.Christiansen I, Thomsen LL, Daugaard D, Ulrich V, Olesen J. Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia. 1999;19:660–667. doi: 10.1046/j.1468-2982.1999.019007660.x. [DOI] [PubMed] [Google Scholar]
  • 36.Afridi SK, Kaube H, Goadsby PJ. Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain. 2004;110:675–680. doi: 10.1016/j.pain.2004.05.007. [DOI] [PubMed] [Google Scholar]
  • 37.Sances G, Tassorelli C, Pucci E, Ghiotto N, Sandrini G, Nappi G. Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches. Cephalalgia. 2004;24:110–119. doi: 10.1111/j.1468-2982.2004.00639.x. [DOI] [PubMed] [Google Scholar]
  • 38.Olesen J, Friberg L, Olsen TS, et al. Timing and topography of cerebral blood-flow, aura, and headache during migraine attacks. Ann Neurol. 1990;28:791–798. doi: 10.1002/ana.410280610. [DOI] [PubMed] [Google Scholar]
  • 39.Thomsen LL. Investigations into the role of nitric oxide and the large intracranial arteries in migraine headache. Cephalalgia. 1997;17:873–895. doi: 10.1046/j.1468-2982.1997.1708873.x. [DOI] [PubMed] [Google Scholar]
  • 40.Thomsen LL, Brennum J, Iversen HK, Olesen J. Effect of a nitric oxide donor (glyceryl trinitrate) on nociceptive thresholds in man. Cephalalgia. 1996;16:169–174. doi: 10.1046/j.1468-2982.1996.1603169.x. [DOI] [PubMed] [Google Scholar]
  • 41.Serrano-Duenas M. High altitude headache. A prospective study of its clinical characteristics. Cephalalgia. 2005;25:H10–1116. doi: 10.1111/j.1468-2982.2005.00968.x. [DOI] [PubMed] [Google Scholar]
  • 42.Mansoor JK, Morrissey BM, Walby WF, et al. L-arginine supplementation enhances exhaled NO, breath condensate VEGF, and headache at 4,342 m. High Alt Med Biol. 2005;6:289–300. doi: 10.1089/ham.2005.6.289. [DOI] [PubMed] [Google Scholar]
  • 43.Arregui A, Leonvelarde F, Cabrera J, Paredes S, Vizcarra D. Umeres H. Migraine, polycythemia and chronic mountain-sickness. Cephalalgia. 1994;14:339–341. doi: 10.1046/j.1468-2982.1994.1405339.x. [DOI] [PubMed] [Google Scholar]
  • 44.Christiansen I, Iversen HK, Olesen J. Headache characteristics during the development of tolerance to nitrates: pathophysiological implications. Cephalalgia. 2000;20:437–444. doi: 10.1046/j.1468-2982.2000.00064.x. [DOI] [PubMed] [Google Scholar]
  • 45.Thomsen LL, Iversen HK, Brinck TA, Olesen J. Arterial super-sensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia. 1993;13:395–399. doi: 10.1046/j.1468-2982.1993.1306395.x. [DOI] [PubMed] [Google Scholar]
  • 46.Bellantonio P, Micieli G, Buzzi MG, et al. Haemodynamic correlates of early and delayed responses to sublingual administration of isosorbide dinitrate in migraine patients: a transcranial Doppler study. Cephalalgia. 1997;17:183–187. doi: 10.1046/j.1468-2982.1997.1703183.x. [DOI] [PubMed] [Google Scholar]
  • 47.Lassen LH, Thomsen LL, Olesen J. Histamine induces migraine via the H-1-receptor. Support for the no hypothesis of migraine. Neuroreport. 1995;6:1475–1479. doi: 10.1097/00001756-199507310-00003. [DOI] [PubMed] [Google Scholar]
  • 48.Lassen LH, Thomsen LL, Krause C, Iversen HK, Olesen J. Histamine-1 receptor blockade does not prevent nitroglycerin induced migraine—support for the NO-hypothesis of migraine. Eur J Clin Pharmacol. 1996;49:335–339. doi: 10.1007/BF00203773. [DOI] [PubMed] [Google Scholar]
  • 49.Krause C, Thomsen LL, Jacobsen TB, Olesen J. The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects. J Cereb Blood Flow Metab. 2002;22:1124–1131. doi: 10.1097/00004647-200209000-00010. [DOI] [PubMed] [Google Scholar]
  • 50.Krause C, Thomsen LL, Birk S, Olesen J. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain. 2003;126:241–247. doi: 10.1093/brain/awg009. [DOI] [PubMed] [Google Scholar]
  • 51.Olesen J, Iversen HK, Thomsen LL. Nitric-oxide supersensitivity—a possible molecular mechanism of migraine pain. Neuroreport. 1993;4:1027–1030. doi: 10.1097/00001756-199308000-00008. [DOI] [PubMed] [Google Scholar]
  • 52.Ashina M, Bendtsen L, Jensen R, Olesen J. Nitric oxide-induced headache in patients with chronic tension-type headache. Brain. 2000;123:1830–1837. doi: 10.1093/brain/123.9.1830. [DOI] [PubMed] [Google Scholar]
  • 53.Ashina M, Bendtsen L, Jensen R, Sakai F, Olesen J. Possible mechanisms of glyceryl-trinitrate-induced immediate headache in patients with chronic tension-type headache. Cephalalgia. 2000;20:919–924. doi: 10.1046/j.1468-2982.2000.00150.x. [DOI] [PubMed] [Google Scholar]
  • 54.Ashina M, Simonsen H, Bendtsen L, Jensen R, Olesen J. Glyceryl trinitrate may trigger endogenous nitric oxide production in patients with chronic tension-type headache. Cephalalgia. 2004;24:967–972. doi: 10.1111/j.1468-2982.2004.00780.x. [DOI] [PubMed] [Google Scholar]
  • 55.Ekbom K. Nitrolglycerin as a provocative agent in cluster headache. Arch Neurol. 1968;19:487–493. doi: 10.1001/archneur.1968.00480050057005. [DOI] [PubMed] [Google Scholar]
  • 56.Ekbom K, Sjostrand C, Svensson DA, Waldenlind E. Periods of cluster headache induced by nitrate therapy and spontaneous remission of angina pectoris during active clusters. Cephalalgia. 2004;24:92–98. doi: 10.1111/j.1468-2982.2004.00634.x. [DOI] [PubMed] [Google Scholar]
  • 57.Christiansen I, Iversen HK, Olesen J. Induction of nitrate tolerance is not a useful treatment in cluster headache. Cephalalgia. 2000;20:445–454. doi: 10.1046/j.1468-2982.2000.00068.x. [DOI] [PubMed] [Google Scholar]
  • 58.May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet. 1998;352:275–278. doi: 10.1016/S0140-6736(98)02470-2. [DOI] [PubMed] [Google Scholar]
  • 59.Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 1995;9:1319–1330. [PubMed] [Google Scholar]
  • 60.Lassen LH, Ashina M, Christiansen I, et al. Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia. 1998;18:27–32. doi: 10.1046/j.1468-2982.1998.1801027.x. [DOI] [PubMed] [Google Scholar]
  • 61.Van Der Kuy PH, Merkus FW, Lohman JJ, ter Berg JW, Hooymans PM. Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study. Cephalalgia. 2002;22:513–519. doi: 10.1046/j.1468-2982.2002.00412.x. [DOI] [PubMed] [Google Scholar]
  • 62.Ikeda Y, Jimbo H, Shimazu M, Satoh K. Sumatriptan scavenges Superoxide, hydroxyl, and nitric oxide radicals: in vitro electron spin resonance study. Headache. 2002;42:888–892. doi: 10.1046/j.1526-4610.2002.02208.x. [DOI] [PubMed] [Google Scholar]
  • 63.Read SJ, Manning P, McNeil CJ, Hunter AJ, Parsons AA. Effects of sumatriptan on nitric oxide and Superoxide balance during glyceryl trinitrate infusion in the rat. Implications for antimigraine mechanisms. Brain Res. 1999;13:847–847. doi: 10.1016/s0006-8993(99)01985-x. [DOI] [PubMed] [Google Scholar]
  • 64.Read SJ, Parsons AA. Sumatriptan modifies cortical free radical release during cortical spreading depression—a novel antimigraine action for sumatriptan? Brain Res. 2000;7:870–870. doi: 10.1016/s0006-8993(00)02400-8. [DOI] [PubMed] [Google Scholar]
  • 65.Wei CC, Wang ZQ, Durra D, et al. The three nitric-oxide synthases differ in their kinetics of tetrahydrobiopterin radical formation, heme-dioxy reduction, and arginine hydroxylation. J Biol Chem. 2005;280:8929–8935. doi: 10.1074/jbc.M409737200. [DOI] [PubMed] [Google Scholar]
  • 66.Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J. Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet. 1999;23:353–353. doi: 10.1016/s0140-6736(98)01079-4. [DOI] [PubMed] [Google Scholar]
  • 67.Ashina M. Nitric oxide synthase inhibitors for the treatment of chronic tension-type headache. Expert Opin Pharmacother. 2002;3:395–399. doi: 10.1517/14656566.3.4.395. [DOI] [PubMed] [Google Scholar]
  • 68.Thomsen LL, Kruuse C, Iversen HK, Olesen J. A nitric oxide donor (nitroglycerin) induces genuine migraine attacks. Eur J Neurol. 1994;1:73–80. doi: 10.1111/j.1468-1331.1994.tb00053.x. [DOI] [PubMed] [Google Scholar]

Articles from Neurotherapeutics are provided here courtesy of Elsevier

RESOURCES